Vaccine Adjuvant
Vaccine adjuvants play vital role in vaccine efficacy
Published in Tuberculosis Week, September 6th, 2004
According to recent research published in the journal Vaccine, "The use of protein or DNA in vaccination process, rather than living or attenuated microorganism, aims at the increase of vaccine safety. However, in these cases, the use of an adjuvant frequently is required to improve immunogenicity. In this study, we show the importance of adjuvant in a vaccine formulation."
"Vaccines for tuberculosis provide an instructive example, based on the mycobacterial 65-kDa heat shock protein (hsp65)," said Karla M. Lima and colleagues at the University of Sao Paulo. "The same antigen can elicit...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Tuberculosis Week
Source: Tuberculosis Week (2004-09-06)
More Articles from Tuberculosis Week
- Tuberculosis Vaccine
Mycobacterial lipoarabinomannan and related lipoglycans reviewed - Tuberculosis Vaccine
New vaccines against tuberculosis entering human clinical trials - Healthcare Access
San Diego emergency and critical care center set to open - Tuberculosis
Case of tuberculosis reported in South Dakota - Tuberculosis
Kansas prisoner possibly infected scores with tuberculosis - Tuberculosis
Second TB-related death this year suspected in Indiana county - More from this issue of Tuberculosis Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
